Recombinant SARS-CoV-2 N354D,D364Y Protein (HEK293)，His

The N354D and D364Y mutations in proteins, particularly in the context of viral pathogens such as the human immunodeficiency virus (HIV), have garnered significant research interest due to their potential impact on viral replication and resistance to antiretroviral therapies. These specific amino acid substitutions can influence the structure and function of the viral enzymes and proteins, potentially altering their interaction with host cell machinery and mediating escape from immune responses or treatment regimens. The N354D mutation is often associated with increased replication capacity in certain strains, while D364Y has been linked to resistance against specific classes of drugs. Understanding the biochemical mechanisms underlying these mutations is crucial for developing effective therapeutics and vaccines. Researchers employ various techniques, including site-directed mutagenesis, protein expression, and functional assays, to investigate the consequences of these mutations on protein function and viral fitness. This research is vital for informing clinical strategies and enhancing our knowledge of viral evolution and resilience, ultimately contributing to improved management of HIV infections and potential cross-applicability to other viral systems.